GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) saw a significant increase in short interest in January. As of January 30th, there was short interest totaling 3,379 shares, an increase of 215.8% from the January 15th total of 1,070 shares. Based on an average trading volume of 25,824 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 25,824 shares, the short-interest ratio is presently 0.1 days.
GeneDx Price Performance
Shares of NASDAQ WGSWW opened at $0.02 on Thursday. GeneDx has a fifty-two week low of $0.01 and a fifty-two week high of $0.34. The business has a 50-day simple moving average of $0.04 and a two-hundred day simple moving average of $0.07.
About GeneDx
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Featured Articles
- Five stocks we like better than GeneDx
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
